Robson et al [12] suggested that a BRCA1 mutation was an independent predictor of breast cancer mortality in a multivariate analysis of a group of women who did not receive chemotherapy, but not in women who received adjuvant chemotherapy. This evidence concerns the gene BRCA1 and breast cancer.